利用智能手机应用程序收集的每日症状数据探究特发性炎症性肌病复发的特征
本研究纳入20例英国成人特发性炎症性肌病患者,通过智能手机应用程序在91天内每日收集患者报告结局指标(PROMs),采用先验定义识别基于症状的复发。结果显示患者报告的复发频繁,复发周各症状评分显著高于非复发周,疲劳相关的症状复发发生率最高。
要点
- 患者报告的复发中位数为每例5周(IQR 3,7),共13周可能复发窗口。
- 复发周肌痛评分均值34/100,非复发周21/100,t检验P值<0.01。
- 疲劳相关症状复发发生率最高(每100人日23次,95%CI 19,27),肌痛最低(每100人日13次,95%CI 11,16)。
核心结论
- 特发性炎症性肌病复发频繁,且与症状评分升高相关。
- 本研究证明可利用应用程序每日收集的数据识别和描述患者报告的和基于症状(先验定义)的复发。
研究设计与样本
- 英国成人特发性炎症性肌病队列,20例参与者(65%为女性),通过智能手机应用程序在91天内每日回答患者报告结局指标。
- 每日症状PROMs包括整体活动、总体疼痛、肌痛、疲劳和无力(0-100视觉模拟量表)。
- 患者报告的复发通过每周应用程序问题记录;基于症状的复发通过先验定义(基于每日症状数据较前4天均值增加)判定。
主要发现
- 患者报告的复发中位数为每例5周(IQR 3,7),共13周可能窗口。
- 复发周各症状评分均值显著高于非复发周,例如复发周肌痛评分均值34/100,非复发周21/100,t检验P值<0.01。
- 疲劳相关症状复发发生率最高(每100人日23次,95%CI 19,27),肌痛最低(每100人日13次,95%CI 11,16)。
- 症状复发通常在3天后缓解,但以疲劳为主的复发持续2天。
- 69%的患者报告复发周至少与一次基于症状的复发重合。
关键数值与推荐
- 基于症状的复发先验定义:每日症状数据较前4天均值增加。
- 症状评分采用0-100视觉模拟量表。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to use daily data collected via a smartphone app for characterization of patient-reported and symptom-based (using an a priori definition) flares in an adult idiopathic inflammatory myopathy (IIM) cohort. METHODS: UK adults with an IIM answered patient-reported outcome measurements (PROMs) daily via a smartphone app during a 91-day study. Daily symptom PROMs addressed global activity, overall pain, myalgia, fatigue, and weakness (on a 0-100 visual analogue scale). Patient-reported flares were recorded via a weekly app question. Symptom-based flares were defined via an a priori definition related to increase in daily symptom data from the previous 4-day mean. RESULTS: Twenty participants (65% female) participated. Patient-reported flares occurred on a median of 5 weeks (IQR 3, 7) per participant, out of a possible 13. The mean of each symptom score was significantly higher in flare weeks, compared with non-flare weeks (e.g. mean flare week myalgia score 34/100, vs 21/100 during non-flare week, t test P-value <0.01). Fatigue accounted for the most symptom-based flares [incidence-rate 23/100 person-days (95% CI 19, 27)], and myalgia the fewest [incidence rate 13/100 person-days (95% CI 11, 16)]. Symptom-based flares typically resolved after 3 days, although fatigue-predominant flares lasted 2 days. The majority (69%) of patient-reported flare weeks coincided with at least one symptom-based flare. CONCLUSIONS: IIM flares are frequent and associated with increased symptom scores. This study has demonstrated the ability to identify and characterize patient-reported and symptom-based flares (based on an a priori definition), using daily app-collected data.
引用
- Oldroyd AGS, Krogh NS, Dixon WG, et al. Investigating characteristics of idiopathic inflammatory myopathy flares using daily symptom data collected via a smartphone app. Rheumatology (Oxford). 2022. PMID: 35274670. doi:10.1093/rheumatology/keac161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。